ABAlessandro Bellofiore

Alessandro Bellofiore

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Alessandro Bellofiore has a total of 45 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Rethinking mechanical heart valves in the aortic position: new paradigms in design and testing

    by Sreyashi Chakraborty, Melinda G. Simon, Alessandro Bellofiore

    Bileaflet mechanical heart valves (MHV) remain a viable option for aortic valve replacement, particularly for younger patients and patients from low- and middle-income countries and underserved communities. Despite their exceptional durability, MHV recipients are at increased risk of thromboembolic complications. As such, the development of the next generation of MHVs must prioritize improved thromboresistance and aim for independence from anticoagulant therapy. However, innovation in MHV design faces several challenges: strict performance and biocompatibility requirements, limited understanding of the mechanisms underlying MHV thrombosis, and a lack of effective testing methodologies to assess how design variations impact both hemodynamic performance and thrombogenicity of MHVs. This paper reviews the emerging paradigms in MHV design, materials and surface modifications that may inspire the development of a new generation of MHVs for aortic valve replacement. We also discuss challenges and opportunities in developing experimental and numerical approaches to achieve a more comprehensive understanding of MHV flow features and the mechanisms of flow-induced blood clotting.


  • Open Access

    Selective Partitioned Regression for Accurate Kidney Health Monitoring

    by Alex Whelan, Ragwa Elsayed, Alessandro Bellofiore, David C. Anastasiu

    The number of people diagnosed with advanced stages of kidney disease have been rising every year. Early detection and constant monitoring are the only minimally invasive means to prevent severe kidney damage or kidney failure. We propose a cost-effective machine learning-based testing system that can facilitate inexpensive yet accurate kidney health checks. Our proposed framework, which was developed into an iPhone application, uses a camera-based bio-sensor and state-of-the-art classical machine learning and deep learning techniques for predicting the concentration of creatinine in the sample, based on colorimetric change in the test strip. The predicted creatinine concentration is then used to classify the severity of the kidney disease as healthy, intermediate, or critical. In this article, we focus on the effectiveness of machine learning models to translate the colorimetric reaction to kidney health prediction. In this setting, we thoroughly evaluated the effectiveness of our novel proposed models against state-of-the-art classical machine learning and deep learning approaches. Additionally, we executed a number of ablation studies to measure the performance of our model when trained using different meta-parameter choices. Our evaluation results indicate that our selective partitioned regression (SPR) model, using histogram of colors-based features and a histogram gradient boosted trees underlying estimator, exhibits much better overall prediction performance compared to state-of-the-art methods. Our initial study indicates that SPR can be an effective tool for detecting the severity of kidney disease using inexpensive lateral flow assay test strips and a smart phone-based application. Additional work is needed to verify the performance of the model in various settings.


  • Estrogen receptor-α prevents right ventricular diastolic dysfunction and fibrosis in female rats

    by Tik-Chee Cheng, Jennifer L. Philip, Diana M. Tabima, Santosh Kumari, Bakhtiyor Yakubov, Andrea L. Frump, Timothy A. Hacker, Alessandro Bellofiore, Rongbo Li, Xin Sun, et al.

    Although women are more susceptible to pulmonary arterial hypertension (PAH) than men, their right ventricular (RV) function is better preserved. Estrogen receptor-α (ERα) has been identified as a likely mediator for estrogen protection in the RV. However, the role of ERα in preserving RV function and remodeling during pressure overload remains poorly understood. We hypothesized that loss of functional ERα removes female protection from adverse remodeling and is permissive for the development of a maladapted RV phenotype. Male and female rats with a loss-of-function mutation in ERα (ERαMut) and wild-type (WT) littermates underwent RV pressure overload by pulmonary artery banding (PAB). At 10 wk post-PAB, WT and ERαMut demonstrated RV hypertrophy. Analysis of RV pressure waveforms demonstrated RV-pulmonary vascular uncoupling and diastolic dysfunction in female, but not male, ERαMut PAB rats. Similarly, female, but not male, ERαMut exhibited increased RV fibrosis, comprised primarily of thick collagen fibers. There was an increased protein expression ratio of TIMP metallopeptidase inhibitor 1 (Timp1) to matrix metalloproteinase 9 (Mmp9) in female ERαMut compared with WT PAB rats, suggesting less collagen degradation. RNA-sequencing in female WT and ERαMut RV revealed kallikrein-related peptidase 10 (Klk10) and Jun Proto-Oncogene (Jun) as possible mediators of female RV protection during PAB. In summary, ERα in females is protective against RV-pulmonary vascular uncoupling, diastolic dysfunction, and fibrosis in response to pressure overload. ERα appears to be dispensable for RV adaptation in males. ERα may be a mediator of superior RV adaptation in female patients with PAH. NEW & NOTEWORTHY Using a novel loss-of-function mutation in estrogen receptor-α (ERα), we demonstrate that female, but not male, ERα mutant rats display right ventricular (RV)-vascular uncoupling, diastolic dysfunction, and fibrosis following pressure overload, indicating a sex-dependent role of ERα in protecting against adverse RV remodeling. TIMP metallopeptidase inhibitor 1 (Timp1), matrix metalloproteinase 9 (Mmp9), kallikrein-related peptidase 10 (Klk10), and Jun Proto-Oncogene (Jun) were identified as potential mediators in ERα-regulated pathways in RV pressure overload. Listen to this article’s corresponding podcast at https://ajpheart.podbean.com/e/role-of-estrogen-receptor-alpha-in-right-ventricular-remodeling/.


  • Open Access

    Impaired Right Ventricular–Vascular Coupling in Young Adults Born Preterm

    by Ashley Mulchrone, Alessandro Bellofiore, Johannes M. Douwes, Neal Duong, Arij G. Beshish, Gregory P. Barton, Christopher J. Francois, Marlowe W. Eldridge, Kara N. Goss, Naomi C. Chesler


  • A novel single-beat approach to assess right ventricular systolic function

    by Alessandro Bellofiore, Rebecca Vanderpool, Melanie J. Brewis, Andrew J. Peacock, Naomi C. Chesler

    Clinical assessment of right ventricular (RV) contractility in diseases such as pulmonary arterial hypertension (PAH) has been hindered by the lack of a robust methodology. Here, a novel, clinically viable, single-beat method was developed to assess end-systolic elastance (Ees), a measure of right ventricular (RV) contractility. We hypothesized that this novel approach reduces uncertainty and interobserver variability in the estimation of the maximum isovolumic pressure (Piso), the key step in single-beat methods. The new method was designed to include a larger portion of the RV pressure data and minimize subjective adjustments by the operator. Data were obtained from right heart catheterization of PAH patients in a multicenter prospective study ( data set 1) and a single-center retrospective study ( data set 2). To obtain Piso, three independent observers used an established single-beat method (based on the first derivative of the pressure waveform) and the novel method (based on the second derivative). Interobserver variability analysis included paired t-test, one-way ANOVA, interclass correlation (ICC) analysis, and a modified Bland-Altman analysis. The Piso values obtained from the two methods were linearly correlated for both data set 1 ( R2 = 0.74) and data set 2 ( R2 = 0.91). Compared with the established method, the novel method resulted in smaller interobserver variability ( P < 0.001), nonsignificant differences between observers, and a narrower confidence interval. By reducing uncertainty and interobserved variability, this novel approach may pave the way for more effective clinical management of PAH. NEW & NOTEWORTHY A novel methodology to assess right ventricular contractility from clinical data is demonstrated. This approach significantly reduces interobserver variability in the analysis of ventricular pressure data, as demonstrated in a relatively large population of subjects with pulmonary hypertension. This study may enable more accurate clinical monitoring of systolic function in subjects with pulmonary hypertension.


  • Open Access

    Imaging right ventricular function to predict outcome in pulmonary arterial hypertension

    by Melanie J. Brewis, Alessandro Bellofiore, Rebecca R. Vanderpool, Naomi C. Chesler, Martin K. Johnson, Robert Naeije, Andrew J. Peacock


  • Accuracy of Doppler echocardiographic estimates of pulmonary artery pressures in a canine model of pulmonary hypertension

    by Lydia C. Soydan, Heidi B. Kellihan, Melissa L. Bates, Rebecca L. Stepien, Daniel W. Consigny, Alessandro Bellofiore, Christopher J. Francois, Naomi C. Chesler


  • Pulmonary artery relative area change is inversely related to ex vivo measured arterial elastic modulus in the canine model of acute pulmonary embolization

    by Lian Tian, Heidi B. Kellihan, Joseph Henningsen, Alessandro Bellofiore, Omid Forouzan, Alejandro Roldán-Alzate, Daniel W. Consigny, McLean Gunderson, Seth H. Dailey, Christopher J. Francois, et al.


  • Right Ventricular Response to Pulmonary Arterial Stiffening in a Canine Model of Acute Embolization

    by Alessandro Bellofiore, Alejandro Roldan-Alzate, Matthieu Besse, Heidi B. Kellihan, Daniel W. Consigny, Christopher J. Francois, Naomi C. Chesler

    Pulmonary arterial hypertension (PAH) is a devastating disease exhibiting fast progression [1] and poor prognosis [2]. PAH originates from an increased resistance to blood flow in the distal pulmonary vasculature and in the later stages of the disease leads to right ventricular (RV) functional impairment and subsequent heart failure, which in most cases is the direct cause of demise. In PAH, RV failure appears to be correlated to PA stiffening, which is a better predictor of mortality than the direct increases in mean pulmonary arterial pressure (mPAP) and pulmonary vasculature resistance (PVR) [3,4].